A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells.
暂无分享,去创建一个
T. Whiteside | R. Melder | R. Herberman | J. Hiserodt | N. Vujanović | T. Whiteside | R. Herberman | Nicola L. Vujanovic